• Skip to primary navigation
  • Skip to content
  • Skip to footer
CardioCell

CardioCell

Breakthrough Cardiovascular Technology

  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Our Stem Cells
    • Manufacturing
    • Quality Control
    • Exclusive License
  • Clinical Trials
    • Overview
    • Chronic Heart Failure
    • Heart Failure in Patients With Left Ventricular Assist Devices
    • Acute Myocardial Infarction
  • News
    • Press Releases
    • Media Coverage
    • Publications
  • Events
  • LinkedIn

Press Releases

December 16, 2015

CardioCell Appoints Timothy Brown, J.D., as Vice President of Intellectual Property

News Dec 16, 2015 CardioCell Appoints Timothy Brown, J.D., as Vice President of Intellectual Property SAN DIEGO — Dec. 16, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, today welcomes Timothy M.

Read More

News,  Press Releases

December 1, 2015

CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure

News Dec 1, 2015 CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure SAN DIEGO — Dec. 1, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, intends to

Read More

News,  Press Releases

November 16, 2015

CardioCell CEO Presents at the World Congress of Regenerative Medicine & Stem Cell – Shanghai 2015

News Nov 16, 2015 CardioCell CEO Presents at the World Congress of Regenerative Medicine & Stem Cell – Shanghai 2015 SHANGHAI, CHINA – WORLD CONGRESS OF REGENERATIVE MEDICINE & STEM CELL 2015 – Nov. 16, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that

Read More

News,  Press Releases

October 28, 2015

CardioCell CEO Presents at BIO-Europe 2015

News Oct 28, 2015 CardioCell CEO Presents at BIO-Europe 2015 MUNICH, GERMANY – BIO-EUROPE 2015 – Oct. 28, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, announces a presentation by CEO Sergey

Read More

News,  Press Releases

October 21, 2015

CardioCell Board Members and Clinical Trial Leads Collaborate on Peer-Reviewed Paper Published in the Journal of Cardiovascular Medicine

News Oct 21, 2015 CardioCell Board Members and Clinical Trial Leads Collaborate on Peer-Reviewed Paper Published in the Journal of Cardiovascular Medicine SAN DIEGO — Oct. 21, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for

Read More

News,  Press Releases

September 1, 2015

CardioCell Scientific Advisory Board Chair Presents at the Stem Cells & Regenerative Medicine Congress 2015

News Sep 1, 2015 CardioCell Scientific Advisory Board Chair Presents at the Stem Cells & Regenerative Medicine Congress 2015 WASHINGTON, D.C. – STEM CELLS & REGENERATIVE MEDICINE CONGRESS 2015 – Sept. 1, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary

Read More

News,  Press Releases

March 10, 2015

CardioCell Adds Stony Brook University to Sites Conducting a Phase IIa Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure

News Mar 10, 2015 CardioCell Adds Stony Brook University to Sites Conducting a Phase IIa Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure STONY BROOK, NEW YORK — March 10, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that designs

Read More

Press Releases

November 20, 2014

University of Pennsylvania Doses First Patient in Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy

News Nov 20, 2014 University of Pennsylvania Doses First Patient in Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy PHILADELPHIA — Nov. 20, 2014 — CardioCell LLC, a Stemedica Cell Technologies Inc.

Read More

News,  Press Releases

  • « Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next Page »

Footer

About Us

  • Overview
  • Board of Directors
  • Scientific Advisory Board

Technology

  • Our Stem Cells
  • Manufacturing
  • Quality Control
  • Exclusive License

Clinical Trials

  • Overview
  • Chronic Heart Failure
  • Heart Failure in Patients With Left Ventricular Assist Devices
  • Acute Myocardial Infarction
<section id="bpfwp_contact_card_widget-1" class="widget widget_bpfwp_contact_card_widget"><div class="widget-wrap"><h3 class="widgettitle widget-title">Contact</h3>
info@stemcardiocell.com
</div></section>

Copyright © 2023 · Business Pro Theme on Genesis Framework · WordPress · Log in